Interviews
Additive proven effective against re-growth of MRSA on treated material
02 Sep '08
2 min read
Universal Detection Technology reported that it has received a purchase order for its anti-microbial washing machine additive from NovaMed. NovaMed plans to use the product to disinfect clothing and linen at its ambulatory surgery centers. UDT's Anti-microbial washing machine additive is effective in sterilizing fabrics and linen from harmful bacteria such as Methicillin-resistant Staphylococcus aureus (MRSA).
MRSA is found worldwide, predominantly in hospitals and institutions such as nursing homes. Recently MRSA has also spread in the general community. There are three main reservoirs (and hence sources of spread and infection) for MRSA in hospital and institutions: staff, patients and inanimate objects such as beds, linen and utensils. Hospitals need to take precautions to prevent the spread of MRSA by sterilizing linen and clothing.
MRSA infections occur in approximately 94,000 persons each year and are associated with approximately 19,000 deaths. Of these infections, about 86% are healthcare-associated and 14% are community-associated.
"The purchase order from NovaMed comes as another milestone for our company as more companies and individuals discover the unique sterilization capabilities of our anti-microbial products," said Mr. Jacques Tizabi, UNDT's Chief Executive Officer.
NovaMed's focus is on the acquisition, development and management of ambulatory surgery centers (ASCs) to provide the best possible experience and outcome for physicians and patients. NovaMed has the resources of a national company, yet is small enough to let clients deal directly with decision makers. NovaMed was founded in 1995 and went public in 1999.
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security.
MRSA is found worldwide, predominantly in hospitals and institutions such as nursing homes. Recently MRSA has also spread in the general community. There are three main reservoirs (and hence sources of spread and infection) for MRSA in hospital and institutions: staff, patients and inanimate objects such as beds, linen and utensils. Hospitals need to take precautions to prevent the spread of MRSA by sterilizing linen and clothing.
MRSA infections occur in approximately 94,000 persons each year and are associated with approximately 19,000 deaths. Of these infections, about 86% are healthcare-associated and 14% are community-associated.
"The purchase order from NovaMed comes as another milestone for our company as more companies and individuals discover the unique sterilization capabilities of our anti-microbial products," said Mr. Jacques Tizabi, UNDT's Chief Executive Officer.
NovaMed's focus is on the acquisition, development and management of ambulatory surgery centers (ASCs) to provide the best possible experience and outcome for physicians and patients. NovaMed has the resources of a national company, yet is small enough to let clients deal directly with decision makers. NovaMed was founded in 1995 and went public in 1999.
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security.
Universal Detection Technology
Popular News
Leave your Comments
Editor’s Pick
Dr. Michael Duetsch & Man Woo Lee
UPM Biochemicals and Dongsung Chemical
Aleksandre Akhalkatsishvili
Label - Aleksandre Akhalkatsishvili
Esteemed Clients
-Ltd..jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Thermore (Far East) Ltd.")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Telangana State Industrial Infrastructure Corporation Limited (TSllC Ltd)")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Taiwan Textile Federation (TTF)")
